<DOC>
	<DOCNO>NCT02321371</DOCNO>
	<brief_summary>In study , patient ACLF ( Acute Chronic Liver Failure ) grade III/IV HE ( Hepatic Encephalopathy ) get admit institute enrol fulfilment inclusion/exclusion criterion consent patient 's attendant . Investigation patient ( mention proforma ) do . Intervention step 1 : liq Lactulose 100 mL stat follow 30 mL/ hourly NG/NJ route + Lactulose enema 3rd hourly - till 4 time soft stool pass , 30 mL enteral route 6th hourly ( If patient bowel sound , enema give ) Intervention step 2 : ( 24 hour introduction step 1 , rapid reduction ammonia &lt; 70mcg/dL ) Randomization L R arm R Arm ( Addition Rifaximin ) Continuation Lactulose + addition Rifaximin 400 mg 8th hourly enteral route L Arm ( Lactulose ) Continuation Lactulose therapy 48 hour .</brief_summary>
	<brief_title>Effect Goal Directed Ammonia Lowering Therapy Acute Chronic Liver Failure Patients With Hepatic Encephalopathy .</brief_title>
	<detailed_description />
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Acute-On-Chronic Liver Failure</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>1 . Age 18 year 2 . Patients ACLF grade III/IV HE 1 . Patients prior decompensation 2 . Grade I , II HE 3 . Chronic HE 4 . CV stroke 5 . Patients ammonia level &lt; 70 mcg/dL 6 . Patients Septic shock 7 . Pregnant lady</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>